Ledger.Open graph →
SEC Form D · filed November 19, 2025

Pelthos Therapeutics Inc

Offering
$18.0M
Sold
$18.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
DURHAM, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Francis Knuettel Ii · Durham, NCExecRichard Malamut · Durham, NCDirectorMatthew Pauls · Durham, NCDirectorRichard Baxter · Durham, NCDirectorPeter Greenleaf · Durham, NCDirectorScott Plesha · Durham, NCExec · DirectorTodd Davis · Durham, NCDirectorEzra Friedberg · Durham, NCDirectorSai Rangarao · Durham, NCExecTodd Davis · Durham, NCDirectorEzra Friedberg · Durham, NCDirectorRichard Malamut · Durham, NCDirectorRichard Baxter · Durham, NCDirectorMatthew Pauls · Durham, NCDirectorFrancis Knuettel Ii · Durham, NCExecPeter Greenleaf · Durham, NCDirectorSai Rangarao · Durham, NCExecScott Plesha · Durham, NCExec · DirectorRichard B. Manchester · Laguna Beach, CADirectorMark Szporka · Orlando, FLDirectorRandy Lubinsky · Orlando, FLDirectorDavid Fleming · Orlando, FLExec · DirectorHugh H. Williamson · Denver, COExecSteven M. Bragg · Denver, CODirectorSamuel J. Camarata · Denver, COExecJack H. Jacobs · Denver, CODirectorTrusten A. Mcartor · Denver, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗